Silk Road Medical, Inc. (SILK): Price and Financial Metrics


Silk Road Medical, Inc. (SILK)

Today's Latest Price: $57.50 USD

1.48 (2.64%)

Updated Nov 27 1:00pm

Add SILK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

SILK Stock Summary

  • With a one year PEG ratio of 0.52, Silk Road Medical Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 6.33% of US stocks.
  • SILK's went public 1.65 years ago, making it older than merely 3.2% of listed US stocks we're tracking.
  • SILK's price/sales ratio is 26.85; that's higher than the P/S ratio of 92.85% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Silk Road Medical Inc are VAPO, PWFL, STIM, AXGN, and NTIC.
  • Visit SILK's SEC page to see the company's official filings. To visit the company's web site, go to silkroadmed.com.

SILK Stock Price Chart Interactive Chart >

Price chart for SILK

SILK Price/Volume Stats

Current price $57.50 52-week high $75.80
Prev. close $56.02 52-week low $20.84
Day low $56.15 Volume 121,500
Day high $57.99 Avg. volume 386,111
50-day MA $64.12 Dividend yield N/A
200-day MA $48.41 Market Cap 1.95B

Silk Road Medical, Inc. (SILK) Company Bio


Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.


SILK Latest News Stream


Event/Time News Detail
Loading, please wait...

SILK Latest Social Stream


Loading social stream, please wait...

View Full SILK Social Stream

Latest SILK News From Around the Web

Below are the latest news stories about Silk Road Medical Inc that investors may wish to consider to help them evaluate SILK as an investment opportunity.

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2020 Results - Earnings Call Transcript

Silk Road Medical, Inc. (SILK) Q2 2020 Earnings Conference Call August 5, 2020 17:00 ET Company Participants Caroline Paul - Investor Relations Erica Rogers - Chief Executive Officer Lucas Buchanan - Chief Financial Officer Conference Call Participants Bob Hopkins - Bank of America Robbie Marcus - JP Morgan Rick Wise...

SA Transcripts on Seeking Alpha | August 10, 2020

Earnings Preview: Silk Road Medical (SILK) Q2 Earnings Expected to Decline

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 29, 2020

Silk Road Medical to Report Second Quarter 2020 Financial Results on August 5, 2020

SUNNYVALE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2020 after market close on Wednesday, August 5, 2020. Company management will host a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 3681776. A live and archived webcast of the event will be available at https://investors.silkroadmed.com/.    About Silk Road Medical Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device co...

Yahoo | July 23, 2020

Health Care Services and Equipment Stocks Poised for Gains

While most attention in health care has been going to large pharma companies, the charts suggest opportunities in niche subsectors.

Yahoo | July 22, 2020

Silk Road Medical names commercial chief

Silk Road Medical (SILK) has promoted five-year veteran Andrew Davis to Chief Commercial Officer. Prior to joining the company, he was VP of Advanced Wound Therapy Sales and Marketing, U.S. and Canada at Acelity....

Seeking Alpha | July 9, 2020

Read More 'SILK' Stories Here

SILK Price Returns

1-mo -5.12%
3-mo -5.71%
6-mo 47.66%
1-year 59.63%
3-year N/A
5-year N/A
YTD 42.40%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7326 seconds.